Freenome, Inc.
Research Freenome, Inc. (FRNM) on Bullrun: market cap USD 129.64M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerFRNM
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyUSD
- Market capUSD 129.64M
- Financial periodFY2025
- RevenueUSD 30.41M
- Revenue growth955.1%
- Net income-USD 219.34M
- Free cash flow-USD 131.72M
- Gross margin93.6%
Valuation Snapshot
latest market cap is USD 129.64M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 30.41M | -USD 219.34M | -USD 131.72M | 93.6% | n/a | USD 78.56M | USD 311.62M | -USD 1.26B |
| FY2024 | USD 2.88M | -USD 274.42M | -USD 256.78M | 11.0% | -2.65 | USD 67.05M | USD 206.52M | -USD 1.06B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-19 | USD 129.64M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 144.21M | 172.1 | n/a | n/a |
| 2024 | 2024-12-31 | USD 112.67M | 59.0 | n/a | n/a |
About Freenome, Inc.
Freenome, Inc., a biotechnology company, develops blood-based screening tests to detect cancer in the United States. The company offers an early cancer detection platform that integrates multiomics, artificial intelligence, and machine learning to uncover complex biological signals associated with cancer.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Freenome, Inc.'s market cap?
Freenome, Inc.'s market capitalization is USD 129.64M.
What does Freenome, Inc. do?
Freenome, Inc., a biotechnology company, develops blood-based screening tests to detect cancer in the United States. The company offers an early cancer detection platform that integrates multiomics, artificial intelligence, and machine learning to uncover complex biological signals associated with cancer. It develops SimpleScreen™ CRC, a blood-based test, including a test for colorectal cancer screening, as well as tests for multi-cancer and multi-disease detection, such as lung, breast, cervical, liver, pancreatic, and esophageal cancers.